RE: Judging by this mornings trading.....19 Dec 2023 14:43
@Colboltblue
In my considered opinion, your best shot at a spike short term will be if following the placing THX merge with EUDA. BUT it will be VERY short lived, you will have almost a third of the stock here in at 6p with their fingers on the sell button plus I genuinely believe that even in the event of a merger a) no cash and I consider little chance of them going on to raise any and b) in the wild unlikely chance they did raise anything they would most certainly renegotiate the terms of the LOI, possibly no cash upfront as market conditions have materially changed and they would be doing their own shareholders a disservice if they didn’t renegotiate a better deal.
IF the merge doesn’t happen then frankly its game over for 201. It’s a 14 year old drug now and modern technologies have likely advanced ahead of it.
As for the 401 deal well its gone to another private company to be positioned. Why VAL can’t do that is beyond me but at the end of the day, do investors want to gamble that another one year old phoenix business will raise north of £20m during 2024? Most unlikely IMO and as such I just think the option won’t be taken up in 2024.
And as for the Labs business, well as I have said many times. Its going to take a heck of a lot of time and more cash. I question spending 600k on building a Biobank catalogue, Imogen had previously spent millions on that biobank and still couldn’t make it financially viable, its all fine and dandy building an amazing Biobank, but you need to secure orders off the back of it. Most UK labs are loss making, the best in the market can only deliver up to a 20% return, its a highly labour-intensive business, they would probably need something like north of £10m revenue generate gross profits to cover existing overheads and that’s assuming no increase in head count. VAL have three scientists, Imogen had something like 36 staff at their height and still couldn’t turn in a result.
My precis is negative I appreciate, no surprise there but you will have plenty of time to buy under the placing price next year, I consider the stock uninvestable with the current BOD and my call is that the SP will drift further in the run up to the AGM June 24 and in September 24 they will be looking at placing 16 most likely at 1p if the BOD still remain. The comment @LWHL made about the board being “haughty” frankly is understatement of the year, I think they are treating shareholders with utter contempt, like you are all idiots that cant read a resolution, and it needs to stop but they can afford to do so as Shareholders keep coming back for more, so why not?
Finally, IF Adam votes Resolution 2 through to grant them 10m of options to distribute amongst themselves he really will tank in shareholders opinions. I really hope he doesn’t do that.
Pork's